Lexington Biosciences Announces Appointment of CEO
16 avr. 2020 18h29 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, April 16, 2020 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (the “Company” or “Lexington”) is pleased to announce the appointment of Donald McInnes as...